[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Gleneadie et al., 2023 - Google Patents

Endogenous bioluminescent reporters reveal a sustained increase in utrophin gene expression upon EZH2 and ERK1/2 inhibition

Gleneadie et al., 2023

View HTML @Full View
Document ID
10806062456515657595
Author
Gleneadie H
Fernandez-Ruiz B
Sardini A
Van de Pette M
Dimond A
Prinjha R
McGinty J
French P
Bagci H
Merkenschlager M
Fisher A
Publication year
Publication venue
Communications Biology

External Links

Snippet

Duchenne muscular dystrophy (DMD) is an X-linked disorder caused by loss of function mutations in the dystrophin gene (Dmd), resulting in progressive muscle weakening. Here we modelled the longitudinal expression of endogenous Dmd, and its paralogue Utrn, in …
Continue reading at www.nature.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology

Similar Documents

Publication Publication Date Title
Austin et al. Molecular mechanisms of arrhythmogenic cardiomyopathy
Tosic et al. Lsd1 regulates skeletal muscle regeneration and directs the fate of satellite cells
Monani Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease
Guimarães-Camboa et al. HIF1α represses cell stress pathways to allow proliferation of hypoxic fetal cardiomyocytes
Koprich et al. Progressive neurodegeneration or endogenous compensation in an animal model of Parkinson's disease produced by decreasing doses of alpha-synuclein
Koss et al. Congenital asplenia in mice and humans with mutations in a Pbx/Nkx2-5/p15 module
Yu et al. A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions
Shpargel et al. UTX and UTY demonstrate histone demethylase-independent function in mouse embryonic development
Edens et al. Molecular mechanisms and animal models of spinal muscular atrophy
Le et al. Temporal requirement for high SMN expression in SMA mice
Franklin et al. The chromatin-binding protein Smyd1 restricts adult mammalian heart growth
Durieux et al. A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice
Koirala et al. GPR56-regulated granule cell adhesion is essential for rostral cerebellar development
Rohani et al. Reversible mitochondrial fragmentation in iPSC-derived cardiomyocytes from children with DCMA, a mitochondrial cardiomyopathy
Welle et al. Skeletal muscle gene expression after myostatin knockout in mature mice
Ng et al. Patient mutations linked to arrhythmogenic cardiomyopathy enhance calpain-mediated desmoplakin degradation
Tsai et al. Genome-wide screening identifies a KCNIP1 copy number variant as a genetic predictor for atrial fibrillation
Cao et al. DACH1 protects podocytes from experimental diabetic injury and modulates PTIP-H3K4Me3 activity
Lancioni et al. Combined deficiency of alpha and epsilon sarcoglycan disrupts the cardiac dystrophin complex
Brennan et al. Mouse model of severe recessive RYR1-related myopathy
Saifudeen et al. A role for p53 in terminal epithelial cell differentiation
Guo et al. Intercalated disc protein Xinβ is required for Hippo-YAP signaling in the heart
Taniguchi et al. RpA1 ameliorates symptoms of mutant ataxin-1 knock-in mice and enhances DNA damage repair
Kim et al. Zinc finger protein 24-dependent transcription factor SOX9 up-regulation protects tubular epithelial cells during acute kidney injury
Wang et al. Negative feedback of SNRK to circ-SNRK regulates cardiac function post-myocardial infarction